FDA Investigator Patricia A Morrow

Patricia A Morrow has conducted inspections on 86 sites in 1 countries as of 25 Mar 2014. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
86
Last Inspection Date:
25 Mar 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Patricia A Morrow:
Amanda B Athey, Amanda B Vega, Amy A Johnson, Amy C Amaro, Ana P Barido, Andrea L Williams Jones, Andrew J Howard, Andrew O Ejiofor, Ann Marie Montemurro, Anthony W Lee, Arduino Frankovic, Armando P Zamora, Ashley M Whitehurst, Austin B Appler, Barbara A Burke, Barbara A Gullick, Barbara J Holladay, Brandon L Mariner, Brian M Palermo, Brooke K Higgins, Brooke K Seeman, Bruce C Kovak, Burnell M Henry, Camilla S Smith, Carole L Jones, Carrie L Doupnik, Cassandra K Johnson, Charles D Boison, Charles E Idjagboro, Charles M Kerns, BLT DO, Cherlita A Honeycutt, Christian D Lynch (CDL), Christine W Twohy, Clarice J Ahn, Colleen F Hoyt, Cynthia A Harris, MD, RN, Danielle R Rainey, David P Rice, Jr, Diane T Bargo, Diane T O'brien, Dung N Tran, Edette J Newby, Edmund F Mrak, Jr, Edward P Potter, Edwin Melendez, Eileen A Liu, Elvis D Morton, Emest F Bizjak, Erika M Wilkerson, Erin L Mcfiren, Frederick F Razzaghi, Gabriel Feng, Gail L Katz, Gale L Glinecki, Gene D Arcy, Gerald Mierle, Heath R Harley, Helen B Ricalde, Holly S Simms, Hyesuk Kong, J David Doleski, Jacqueline Johnson, Jacquelyn D Hokamp, James L Kenney, DSc, James M Simpson, James T Mccoy, James W Leonette, Jamie D Swann, Jeanne D Shaffer, Jeffrey A Reed, Jessica D Nanini, Jessica D Weber, John Dan, John M Gusto, John M Mcinnis, Johnson, Jonathan W Chapman, Joseph W Matthews, Jude C Dikes, Julie A Silberberg, Justin A Hefferman, Justin H Price, Karen M Cooper, Kellie L Westerbuhr, Kelly Dragon, Kenneth L Smalls, Krista N Flores, La Tasham Gunter, Lakisha M Williams, Latoya S Oliver Powell, Laurissa S Flowers, LCDR Anastasia M Piliafas Brown, LCDR Cornelius Brown, III, Linda S Mattingly, Lori S Lawless, Lorraine L Chavis, LT John M Mastalski, Lynette P Salisbury, Marc S Neubauer, Marcellinus D Dordunoo, Margaret Torres Vazquez, Marion W Nadeau, Mary T Carden, Matthew M Henciak, Melissa D Kalik, Melissa J Garcia, Merideth K Rose, Michael L Zimmerman, Michelle E Noonan Smith, Mildred L Mccray, Mohamad A Chahine, Monique Rac Lester, Myra L Gemmill, Myra L Reed, Nancy L Meade, Nancy L Rose, Natasha A Dezinna, Natasha A Harry, Nebil A Oumer, Nerizza B Guerin, Nina D Patel, Normica G Facey, Osama M Hamoud, Paula J Bretz, Prabhu P Raju, Priscilla M Pastrana, Rachael A Wiederock, Rachel C Harrington, Rebecca Rodriguez, Regina Gibson Melton, Renisha M Shaw, Richard J Bashay, Robert Jennings, Rona A Leblanc, PhD, Ronald T Nowalk, Samuel M Aboagye, Sarah M Shannon, Sharon K Thoma, PharmD, Shavon L Square, Sherry L Secrist, BLT DO, Shirshendu K Deb, PhD, Shusheen A Alexander, Sidney B Priesmeyer, Stacey A Priest, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Steven P Donald, Susan M Jackson, Suzanne M Healy, Suzanne M Muchene, Tajah L Blackburn, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Theresa M Smedley, Thomas W Nojek, Troy C Quander, Valerie G Vallely, Victoria V Bot, Vipulchandra N Dholakia, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, Wayne L Jefferson, William D Murray, William J Leonard

Patricia A Morrow's Documents

Publish Date Document Type Title
July, 2013 FDA 483 Bell-More Labs Inc - Form 483, 2013-07-25
July, 2011 EIR Osiris Therapeutics Inc - EIR, 2011-07-14
November, 2008 EIR PAREXEL INTERNATIONAL CORPORATION - EIR, 2008-11-18
February, 2012 FDA 483 Response Inova Health Care Services - Form 483R, 2012-03-15
February, 2012 FDA 483 Inova Health Care Services - Form 483, 2012-03-14
January, 2010 EIR Fisher Bioservices - EIR, 2010-01-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more